Rates and reasons for discontinuation of triptans and opioids in episodic migraine: Results from the American migraine prevalence and prevention (AMPP) study

Starr Holland, Kristina M. Fanning, Daniel Serrano, Dawn C. Buse, Michael L. Reed, Richard B. Lipton

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Rates and reasons for discontinuation of triptans and opioids in episodic migraine: Results from the American migraine prevalence and prevention (AMPP) study'. Together they form a unique fingerprint.

Medicine & Life Sciences